US20040106794A1
(en)
*
|
2001-04-16 |
2004-06-03 |
Schering Corporation |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
ES2201909B1
(en)
*
|
2002-06-06 |
2005-02-16 |
Universitat De Valencia Estudi General. |
USE OF N- (2-CHLOROPIRIDIN-4-IL) -N'-PHENYLURES AND N- (3-NITROPHENYL) -N'-FLUORATED PHENYLURES AS PROMOTERS OF FRUIT GROWTH IN CROPS OF DELICIOUS ACTINIDIA.
|
CN100497302C
(en)
*
|
2002-09-05 |
2009-06-10 |
神经研究公司 |
Diarylurea derivatives and their use as chloride channel blockers
|
WO2004022525A1
(en)
*
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
JP2006507329A
(en)
*
|
2002-11-21 |
2006-03-02 |
ニューロサーチ、アクティーゼルスカブ |
Novel arylureidobenzoic acid derivatives and uses thereof
|
JP2006527735A
(en)
*
|
2003-06-17 |
2006-12-07 |
ノイロサーチ アクティーゼルスカブ |
Diphenylurea derivatives and their use as chloride channel blockers
|
DK1558582T3
(en)
|
2003-07-22 |
2006-05-08 |
Arena Pharm Inc |
Diaryl and arylheteroarlurea derivatives as modulators of the activity of the 5-HT2A serotonin receptor useful for the prophylaxis or treatment of disorders related thereto
|
CN1926114B
(en)
|
2004-03-23 |
2011-08-24 |
艾尼纳制药公司 |
Processes for preparing substituted N-aryl-N'-[3-(1H-pyrazol-5-yl) phenyl] ureas and intermediates thereof
|
DE102004046492A1
(en)
*
|
2004-09-23 |
2006-03-30 |
Sanofi-Aventis Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
|
SA05260357B1
(en)
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
3-phenyle-pyrazole derivatives as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto
|
US7915316B2
(en)
*
|
2005-08-22 |
2011-03-29 |
Allergan, Inc |
Sulfonamides
|
CN101365690A
(en)
|
2005-10-12 |
2009-02-11 |
沃泰克斯药物股份有限公司 |
Biphenyl derivatives as modulators of voltage gated ion channels
|
US7820821B2
(en)
|
2006-02-10 |
2010-10-26 |
Transtech Pharma, Inc. |
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
|
WO2007136680A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
EP2018372B1
(en)
|
2006-05-18 |
2015-05-13 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
|
EP2018371B1
(en)
|
2006-05-18 |
2015-03-04 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
TWI415845B
(en)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
WO2009023253A2
(en)
|
2007-08-15 |
2009-02-19 |
Arena Pharmaceuticals Inc. |
IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
US8618090B2
(en)
*
|
2008-07-23 |
2013-12-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitors of the plasmodial surface anion channel as antimalarials
|
NZ590474A
(en)
|
2008-07-23 |
2012-10-26 |
Arena Pharm Inc |
SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
|
AU2009276744A1
(en)
|
2008-07-28 |
2010-02-04 |
Polymedix, Inc. |
Anti-malarial compounds
|
EA036955B1
(en)
|
2008-08-27 |
2021-01-19 |
Арена Фармасьютикалз, Инк. |
Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
DK2364142T3
(en)
|
2008-10-28 |
2018-04-30 |
Arena Pharm Inc |
COMPOSITIONS OF A 5-HT2A SEROTONIN RECEPTOR MODULATOR USED FOR TREATMENT OF DISEASES RELATED TO THE RECEPTOR
|
WO2011075596A1
(en)
|
2009-12-18 |
2011-06-23 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
CN108558740B
(en)
|
2010-01-27 |
2021-10-19 |
艾尼纳制药公司 |
S1P1 receptor modulators and salts thereof
|
CN105503882B
(en)
|
2010-03-03 |
2019-07-05 |
艾尼纳制药公司 |
The method for preparing S1P1 receptor modulators and its crystal form
|
DE102012007558A1
(en)
*
|
2012-04-14 |
2013-10-17 |
Alf Hammes |
Use of diarylurea-derivatives for treating the symptoms of anemia, thalassemia, sickle cell anemia and Diamond-Blackfan anemia
|
JP6463366B2
(en)
|
2013-10-10 |
2019-01-30 |
イースタン バージニア メディカル スクール |
4-((2-Hydroxy-3-methoxybenzyl) amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
|
AU2016205361C1
(en)
|
2015-01-06 |
2021-04-08 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
US10022355B2
(en)
|
2015-06-12 |
2018-07-17 |
Axovant Sciences Gmbh |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder
|
BR112017027656B1
(en)
|
2015-06-22 |
2023-12-05 |
Arena Pharmaceuticals, Inc. |
CRYSTALLINE HABIT OF SALT-FREE PLATE OF ACID L-ARGININE (R)-2-(7-(4- CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)- 1,2,3,4-TETRA-HYDROCYCLO-PENTA[B ]INDOL-3- IL)ACETIC, PHARMACEUTICAL COMPOSITION THAT COMPRISES IT, ITS USES AND METHOD OF PREPARATION THEREOF
|
RU2018103338A
(en)
|
2015-07-15 |
2019-08-15 |
Аксовант Сайенсиз Гмбх |
Derivatives of diaryl and arylheteroarylureas for the prevention and treatment of hallucinations associated with a neurodegenerative disease
|
JP2020507611A
(en)
|
2017-02-16 |
2020-03-12 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
Compounds and methods for the treatment of primary biliary cholangitis
|
WO2018151834A1
(en)
|
2017-02-16 |
2018-08-23 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
|
WO2019047094A1
(en)
*
|
2017-09-07 |
2019-03-14 |
Eli Lilly And Company |
Cyclobutyl-imidazolidinone compounds
|
US10370352B2
(en)
|
2017-09-07 |
2019-08-06 |
Eli Lilly And Company |
Cyclobutyl-imidazolidinone compounds
|
US11555015B2
(en)
|
2018-09-06 |
2023-01-17 |
Arena Pharmaceuticals, Inc. |
Compounds useful in the treatment of autoimmune and inflammatory disorders
|
WO2020079051A1
(en)
*
|
2018-10-16 |
2020-04-23 |
Scandion Oncology A/S |
Compounds for treatment of microbial infection
|
JP7336133B2
(en)
*
|
2019-08-07 |
2023-08-31 |
国立大学法人東北大学 |
Diphenylurea compound derivative
|
TW202322824A
(en)
|
2020-02-18 |
2023-06-16 |
美商基利科學股份有限公司 |
Antiviral compounds
|
CN117120444A
(en)
|
2021-04-16 |
2023-11-24 |
吉利德科学公司 |
Method for preparing carbanucleoside using amide
|